Targeting EGFR with photodynamic therapy in combination with Erbitux enhances in vivo bladder tumor response.

Bhuvaneswari, Ramaswamy

Targeting EGFR with photodynamic therapy in combination with Erbitux enhances in vivo bladder tumor response. [electronic resource] - Molecular cancer Nov 2009 - 94 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1476-4598

10.1186/1476-4598-8-94 doi


Animals
Antibodies, Monoclonal--pharmacology
Antibodies, Monoclonal, Humanized
Apoptosis--drug effects
Cetuximab
Combined Modality Therapy
ErbB Receptors--antagonists & inhibitors
Gene Expression Regulation, Neoplastic--drug effects
Humans
Mice
Phosphorylation--drug effects
Photochemotherapy
Remission Induction
Urinary Bladder Neoplasms--drug therapy
Xenograft Model Antitumor Assays